Showing 3 of 3 recruiting trials for “Sclerosing cholangitis”
DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
RecruitingNCT06781242 ↗
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
👨⚕️ Giovanni Vitale, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 2 sites📅 Started Jan 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →